2nd Quarter - Report
OGR for SMITHS GROUP PLC
Firm
Client
Income
$40,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Medical device technology related to the opioid epidemic and the COVID-19 pandemic. S.586/H.R.3259, NOPAIN Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CONRAD LASS | — |
| JEROME MURRAY | — |
| TUCKER SHUMACK | — |
| KARISSA WILLHITE | — |
Environment/Superfund ENV
General discussions related to hydrogen technology and development. General discussions regarding technical expertise in sealing device technology and emissions reductions. Monitor issues related to PFAS; H.R.2467, PFAS Action Act of 2021.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CONRAD LASS | — |
| JEROME MURRAY | — |
| TUCKER SHUMACK | — |
| KARISSA WILLHITE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.